Fast track for dementia drug good news for Axovant and new CEO June 19, 2017 Axovant has gained FDA fast track designation for its pipeline drug nelotanserin, a treatment for visual hallucinations suffered Share X Fast track for dementia drug good news for Axovant and new CEO https://pharmaphorum.com/news/fast-track-dementia-drug-good-news-axovant-new-ceo/
